Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1985 1
1987 1
1988 2
1989 3
1990 3
1991 12
1992 6
1993 3
1994 16
1995 6
1996 11
1997 22
1998 13
1999 24
2000 13
2001 14
2002 20
2003 16
2004 19
2005 15
2006 14
2007 21
2008 11
2009 15
2010 20
2011 15
2012 19
2013 22
2014 31
2015 63
2016 77
2017 58
2018 70
2019 90
2020 104
2021 54
Text availability
Article attribute
Article type
Publication date

Search Results

821 results
Results by year
Filters applied: . Clear all
Page 1
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
Younossi Z, Tacke F, Arrese M, Chander Sharma B, Mostafa I, Bugianesi E, Wai-Sun Wong V, Yilmaz Y, George J, Fan J, Vos MB. Younossi Z, et al. Hepatology. 2019 Jun;69(6):2672-2682. doi: 10.1002/hep.30251. Hepatology. 2019. PMID: 30179269 Free article. Review.
Because of the close association of NAFLD with type 2 diabetes (T2DM) and obesity, the latest models predict that the prevalence of NAFLD and NASH will increase, causing a tremendous clinical and economic burden and poor patient-reported outcomes. Nonetheless, there is no …
Because of the close association of NAFLD with type 2 diabetes (T2DM) and obesity, the latest models predict that the prevalence of NAFLD an …
Abnormal Liver Function Tests in Patients With COVID-19: Relevance and Potential Pathogenesis.
Bertolini A, van de Peppel IP, Bodewes FAJA, Moshage H, Fantin A, Farinati F, Fiorotto R, Jonker JW, Strazzabosco M, Verkade HJ, Peserico G. Bertolini A, et al. Hepatology. 2020 Nov;72(5):1864-1872. doi: 10.1002/hep.31480. Epub 2020 Oct 20. Hepatology. 2020. PMID: 32702162 Free PMC article. Review.
In conclusion, these initial observations suggest that the prevalence of abnormal LFTs is high in COVID-19 patients, but that the clinical relevance is limited and that treatment is not required. The mechanisms underlying abnormal LFTs in COVID-19 are likely multifactorial …
In conclusion, these initial observations suggest that the prevalence of abnormal LFTs is high in COVID-19 patients, but that the clinica
Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances.
Sirica AE, Gores GJ, Groopman JD, Selaru FM, Strazzabosco M, Wei Wang X, Zhu AX. Sirica AE, et al. Hepatology. 2019 Apr;69(4):1803-1815. doi: 10.1002/hep.30289. Epub 2019 Mar 25. Hepatology. 2019. PMID: 30251463 Free PMC article. Review.
An integrated systems approach to classifying heterogeneous iCCA subtypes will be further highlighted, and recent clinical trials and emerging targeted therapies will be reviewed, along with recommendations for future translational research opportunities. Established inter …
An integrated systems approach to classifying heterogeneous iCCA subtypes will be further highlighted, and recent clinical trials and …
Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis.
Younossi ZM, Loomba R, Anstee QM, Rinella ME, Bugianesi E, Marchesini G, Neuschwander-Tetri BA, Serfaty L, Negro F, Caldwell SH, Ratziu V, Corey KE, Friedman SL, Abdelmalek MF, Harrison SA, Sanyal AJ, Lavine JE, Mathurin P, Charlton MR, Goodman ZD, Chalasani NP, Kowdley KV, George J, Lindor K. Younossi ZM, et al. Hepatology. 2018 Jul;68(1):349-360. doi: 10.1002/hep.29721. Hepatology. 2018. PMID: 29222917 Free PMC article.
In Asia, a gradient of high to low prevalence rates is noted from urban to rural areas. Given the prevalence of NAFLD, the clinical and economic burden of NAFLD and NASH can be substantial. ...In summary, developing safe and easily accessible noninvasive modalities to accu …
In Asia, a gradient of high to low prevalence rates is noted from urban to rural areas. Given the prevalence of NAFLD, the clinical a …
A practical approach to nutritional screening and assessment in cirrhosis.
Tandon P, Raman M, Mourtzakis M, Merli M. Tandon P, et al. Hepatology. 2017 Mar;65(3):1044-1057. doi: 10.1002/hep.29003. Epub 2017 Feb 6. Hepatology. 2017. PMID: 28027577 Review.
This article summarizes the clinically relevant evidence and presents key issues, tools, and clinical options that are applicable to patients with cirrhosis. The definition, etiology, and clinically relevant outcomes associated with malnutrition are reviewed. ...Multicente …
This article summarizes the clinically relevant evidence and presents key issues, tools, and clinical options that are applicable to …
Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps.
Lonardo A, Nascimbeni F, Ballestri S, Fairweather D, Win S, Than TA, Abdelmalek MF, Suzuki A. Lonardo A, et al. Hepatology. 2019 Oct;70(4):1457-1469. doi: 10.1002/hep.30626. Epub 2019 Sep 23. Hepatology. 2019. PMID: 30924946 Free PMC article. Review.
Based on computer modeling, female and male livers are metabolically distinct with unique regulators modulating sex-specific metabolic outcomes. Analysis of the literature reveals that most published clinical and epidemiological studies fail to examine sex differences appr …
Based on computer modeling, female and male livers are metabolically distinct with unique regulators modulating sex-specific metabolic outco …
Liver Injury and Failure in Critical Illness.
Horvatits T, Drolz A, Trauner M, Fuhrmann V. Horvatits T, et al. Hepatology. 2019 Dec;70(6):2204-2215. doi: 10.1002/hep.30824. Hepatology. 2019. PMID: 31215660 Review.
., hemodynamic, inflammatory, or drug induced) is key to a better understanding of clinical manifestations, prognostic implications, as well as diagnostic and therapeutic options of acquired liver injury and failure. ...
., hemodynamic, inflammatory, or drug induced) is key to a better understanding of clinical manifestations, prognostic implications, …
The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD.
Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, Enders F, Saksena S, Burt AD, Bida JP, Lindor K, Sanderson SO, Lenzi M, Adams LA, Kench J, Therneau TM, Day CP. Angulo P, et al. Hepatology. 2007 Apr;45(4):846-54. doi: 10.1002/hep.21496. Hepatology. 2007. PMID: 17393509
We constructed and validated a scoring system consisting of routinely measured and readily available clinical and laboratory data to separate NAFLD patients with and without advanced fibrosis. A total of 733 patients with NAFLD confirmed by liver biopsy were divided into 2 …
We constructed and validated a scoring system consisting of routinely measured and readily available clinical and laboratory data to …
821 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page